L. Guéganton

5.0k total citations
9 papers, 19 citations indexed

About

L. Guéganton is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, L. Guéganton has authored 9 papers receiving a total of 19 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Pulmonary and Respiratory Medicine, 2 papers in Oncology and 2 papers in Public Health, Environmental and Occupational Health. Recurrent topics in L. Guéganton's work include Cystic Fibrosis Research Advances (4 papers), Lung Cancer Research Studies (2 papers) and Advanced Breast Cancer Therapies (1 paper). L. Guéganton is often cited by papers focused on Cystic Fibrosis Research Advances (4 papers), Lung Cancer Research Studies (2 papers) and Advanced Breast Cancer Therapies (1 paper). L. Guéganton collaborates with scholars based in France, Netherlands and United Kingdom. L. Guéganton's co-authors include G. Rault, Dominique Bertrand, Pierre Lombrail, Emmanuel Nowak, Robert D. Gray, Véronique Witko‐Sarsat, Dominique Mottier, Nadège Loaëc, Adriano G. Rossi and K. Hubeaux and has published in prestigious journals such as Orphanet Journal of Rare Diseases, Journal of Cystic Fibrosis and Science Technology and Society.

In The Last Decade

L. Guéganton

6 papers receiving 19 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
L. Guéganton France	3	12	4	3	3	2	9	19
Awoke Masrie Ethiopia	2	4 0.3×	5 1.3×	2 0.7×	2 0.7×		8	12
Gerd Nettekoven Germany	3	7 0.6×	3 0.8×		6 2.0×	1 0.5×	7	19
Marianne Tinkler United Kingdom	2	9 0.8×	2 0.5×	2 0.7×			7	11
Michelle A. Fischer United States	4	6 0.5×	2 0.5×	2 0.7×			9	26
Hélène Lafoeste France	4	18 1.5×	6 1.5×			2 1.0×	5	32
Chris Price Singapore	2	11 0.9×	4 1.0×	1 0.3×		1 0.5×	3	16
Shana Criscitiello United States	2	9 0.8×	3 0.8×				4	13
Natalya Alekhina United States	4	5 0.4×	5 1.3×	6 2.0×			5	26
C. Rolland France	3	6 0.5×	4 1.0×				6	20
Coralie Courtinard France	3	4 0.3×	4 1.0×		5 1.7×		8	11

Countries citing papers authored by L. Guéganton

Since Specialization

Citations

This map shows the geographic impact of L. Guéganton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L. Guéganton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L. Guéganton more than expected).

Fields of papers citing papers by L. Guéganton

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by L. Guéganton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L. Guéganton. The network helps show where L. Guéganton may publish in the future.

Co-authorship network of co-authors of L. Guéganton

This figure shows the co-authorship network connecting the top 25 collaborators of L. Guéganton. A scholar is included among the top collaborators of L. Guéganton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with L. Guéganton. L. Guéganton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

1.

Ramel, Sophie, L. Guéganton, Emmanuel Nowak, et al.. (2024). Sexual dysfunction in cystic fibrosis. Journal of Cystic Fibrosis. 23(4). 647–652.

2.

Guéganton, L., et al.. (2018). Lessons from the on-site quality audit of data transmitted to the French cystic fibrosis registry. Orphanet Journal of Rare Diseases. 13(S1). 9–9. 6 indexed citations

3.

Meijer, Lisethe, Geneviève Héry-Arnaud, Rozenn Le Berre, et al.. (2016). ePS03.7 Rosco-CF, a safety and efficacy clinical trial of (R)-roscovitine in CF patients. Journal of Cystic Fibrosis. 15. S42–S42. 3 indexed citations

4.

Meijer, Laurent, David Nelson, Vladimir Riazanski, et al.. (2015). 134 Rationale for evaluating (R)-roscovitine (Seliciclib) in patients with cystic fibrosis. Journal of Cystic Fibrosis. 14. S92–S92. 1 indexed citations

5.

Guéganton, L., et al.. (2013). The Reconfiguration of the Relationship to Care for a Rare Disease: Neonatal Expended Screening in a Socio-material Perspective. Science Technology and Society. 18(1). 115–138. 1 indexed citations

6.

Rault, G., et al.. (2012). WS19.4 CF quality improvement program: a pilot phase to experiment the US QIP approach in France. Journal of Cystic Fibrosis. 11. S43–S43. 2 indexed citations

7.

Guéganton, L., et al.. (2011). L'expérience professionnelle du médecin hospitalier à l'épreuve du dépistage : le cas de l'annonce du diagnostic de la mucoviscidose. Revue française des affaires sociales. 80–102. 6 indexed citations

8.

Guéganton, L., et al.. (2009). CF Diagnosis Announcement Practices following a neonatal screening in France. Journal of Cystic Fibrosis. 8. S13–S13.

9.

Guéganton, L., et al.. (2006). 487 Procedure for diagnostic announcement of Cystic Fibrosis by a multidisciplinary team. Journal of Cystic Fibrosis. 5. S107–S107.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact